VTGN

$0.16872.12%0.0035

Vistagen Therapeutics Inc (VTGN)

Vistagen Therapeutics Inc Stock (VTGN) Forecast

The Vistagen Therapeutics Inc (VTGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $0.1729, representing a +2.49% increase from the current price of $0.1687. The highest analyst price target is $0.1161, and the lowest is $0.2297.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month VTGN Price Target

Average 0.8646 (+412.49% Upside)

Is Vistagen Therapeutics Inc (VTGN) A Buy Now?

Oscillators

Name	Value	Action
RSI(14)	35.78	Neutral
STOCH(9,6)	19.34	Buy
STOCHRSI(14)	59.93	Neutral
MACD(12,26)	-0.02	Buy
ADX(14)	13.30	Neutral
William %R	-91.74	Buy
CCI(14)	-20.20	Neutral

Buy: 3 · Sell: 0 · Neutral: 4Summary: Neutral

Moving Averages

Period	Simple	Exponential
MA10	0.17 Sell	0.18 Sell
MA20	0.19 Sell	0.19 Sell
MA50	0.23 Sell	0.23 Sell
MA100	0.27 Sell	0.32 Sell
MA200	0.43 Sell	0.79 Sell

Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, VTGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 10 signaling Sell signals and 4 Neutral signals. This might not be a good time to consider opening new positions on VTGN, as trading bearish markets can be challenging and may result in losses.

RSI (Relative Strength Index): The RSI(14) value of 35.78 indicates that VTGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
STOCH (Stochastic Oscillator): The STOCH value of 19.34 indicates that VTGN is oversold. This indicates that VTGN price is at or near the lowest level over a specified lookback period.
STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 59.93 indicates that VTGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
ADX (Average Directional Index): The ADX value of 13.30 suggests that there may be some movement in price, but it lacks strength or conviction.
CCI (Commodity Channel Index): A CCI(14) value of -20.20 indicates that VTGN is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term VTGN price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Vistagen Therapeutics Inc financial reports and earnings history, Vistagen Therapeutics Inc (VTGN) stock could reach $2.80 by 2030, $20.56 by 2040 and $8.70 by 2050. See the projected annual prices until 2050 of the Vistagen Therapeutics Inc stock below:

Vistagen Therapeutics Inc (VTGN) is expected to reach an average price of $0.8371 in 2035, with a high prediction of $3.47 and a low estimate of $0.6914. This indicates an +396.23% change from the last recorded price of $0.1687.
Vistagen Therapeutics Inc (VTGN) stock is projected to chart a bullish course in 2040, with an average price target of $1.20, representing an +610.20% change from its current level. The forecast ranges from a conservative $0.0861 to a sky-high $20.56.
Our analysts predict Vistagen Therapeutics Inc (VTGN) to change +892.95% by 2045, soaring from $0.2814 to an average price of $1.68, potentially reaching $19.17. While $0.2814 is the low estimate, the potential upside is significant.
Vistagen Therapeutics Inc (VTGN) stock is expected to climb by 2050, reaching an average of $7.56, a +4,380% change from its current level. However, a wide range of estimates exists, with high and low targets of $8.70 and $7.57, respectively, highlighting the market's uncertainty.

Vistagen Therapeutics Inc Stock (VTGN) Year by Year Forecast

Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2026

The predicted value for Vistagen Therapeutics Inc (VTGN) in 2026 is set at an average of $0.3569. Estimates vary from a peak of $0.7997 to a trough of $0.0416, indicating an +111.57% surge from the present price of $0.1687.

Month	Average	Low	High	Change from today's price
December, 2026	$0.0203	$0.2297	$0.1161	-87.95%

Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Vistagen Therapeutics Inc (VTGN) is $1.03, with a high forecast of $1.60 and a low forecast of $0.1325. This indicates an +512.15% increase from the last price of $0.1687.

Month	Average	Low	High	Change from today's price
January, 2027	$0.4839	$0.1325	$0.2339	+186.83%
February, 2027	$0.4581	$0.461	$0.341	+171.54%
March, 2027	$0.7359	$0.5588	$0.6259	+336.19%
April, 2027	$0.7501	$0.7601	$0.6601	+344.62%
May, 2027	$0.5978	$0.5607	$0.4843	+254.38%
June, 2027	$0.692	$0.782	$0.7085	+310.22%
July, 2027	$0.8325	$0.7356	$0.7927	+393.45%
August, 2027	$1.63	$0.9402	$0.8934	+868.66%
September, 2027	$1.54	$1.61	$1.60	+814.78%
October, 2027	$1.53	$1.57	$1.56	+804.41%
November, 2027	$1.59	$1.55	$1.56	+841.68%
December, 2027	$1.55	$1.55	$1.57	+819.04%

Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2028

In 2028, Vistagen Therapeutics Inc (VTGN) is projected to reach an average price of $1.60, with a high projection of $23.33 and a low estimate of $0.1906. This indicates an +846.90% rise from the last price of $0.1687.

Month	Average	Low	High	Change from today's price
January, 2028	$1.51	$1.51	$1.51	+793.12%
February, 2028	$1.51	$1.52	$1.51	+797.09%
March, 2028	$1.38	$1.43	$1.44	+717.25%
April, 2028	$1.37	$1.35	$1.33	+710.86%
May, 2028	$1.39	$1.38	$1.37	+726.61%
June, 2028	$1.37	$1.38	$1.37	+711.08%
July, 2028	$1.34	$1.34	$1.35	+692.57%
August, 2028	$0.7403	$1.33	$1.81	+338.84%
September, 2028	$0.397	$0.1906	$1.06	+135.34%
October, 2028	$0.2893	$0.2335	$0.5363	+71.46%
November, 2028	$3.97	$3.36	$23.33	+2,250%
December, 2028	$3.91	$3.73	$6.00	+2,218%

Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2029

The 2029 price forecast for Vistagen Therapeutics Inc Stock (VTGN) is $3.10 on average, with a high prediction of $4.64 and a low estimate of $1.16. This represents an +1,737% increase from the previous price of $0.1687.

Month	Average	Low	High	Change from today's price
January, 2029	$1.61	$1.57	$4.38	+856.17%
February, 2029	$2.10	$1.16	$2.33	+1,144%
March, 2029	$3.39	$1.96	$3.92	+1,912%
April, 2029	$4.23	$2.92	$4.64	+2,406%
May, 2029	$3.57	$3.29	$4.27	+2,018%
June, 2029	$3.94	$3.25	$4.37	+2,235%
July, 2029	$4.14	$2.76	$4.53	+2,354%
August, 2029	$3.64	$3.28	$4.61	+2,056%
September, 2029	$3.35	$3.21	$3.85	+1,887%
October, 2029	$2.29	$2.10	$3.42	+1,260%
November, 2029	$2.63	$2.13	$3.17	+1,459%
December, 2029	$2.28	$2.05	$2.99	+1,253%

Vistagen Therapeutics Inc Stock (VTGN) Price Forecast for 2030

Vistagen Therapeutics Inc Stock (VTGN) is expected to reach an average price of $1.86 in 2030, with a high forecast of $2.80 and a low forecast of $1.15. This signifies an +1,002% surge from the last price of $0.1687.

Month	Average	Low	High	Change from today's price
January, 2030	$2.32	$2.08	$2.80	+1,274%
February, 2030	$2.06	$1.98	$2.37	+1,124%
March, 2030	$2.16	$1.85	$2.31	+1,180%
April, 2030	$1.95	$1.59	$2.35	+1,057%
May, 2030	$1.71	$1.35	$2.02	+912.40%
June, 2030	$2.08	$1.66	$2.55	+1,135%
July, 2030	$2.13	$1.79	$2.29	+1,160%
August, 2030	$2.01	$1.69	$2.19	+1,092%
September, 2030	$1.36	$1.15	$2.19	+708.51%
October, 2030	$1.52	$1.26	$1.72	+800.86%
November, 2030	$1.67	$1.49	$1.95	+887.28%
December, 2030	$1.34	$1.26	$1.81	+692.99%

Similar to VTGN